- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 4d ago↗ source
- FDA cites companies for CGMP violations, informed consent failure<p>The US Food and Drug Administration has issued warning letters to several drug makers for failing to meet its current good manufacturing practices (CGMP) requirements and a company for failing t…raps · 4d ago↗ source
- European Commission publishes guideline on transparency obligations under AI Act<p>The European Commission on Monday published new guidelines to assist providers and deployers of artificial intelligence (AI) systems in fulfilling transparency obligations under the EU’s AI Act,…